$45.37
-0.03 (-0.07%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-71.8% upside
Low Target
$8.80
Average Target
$12.80
High Target
$18.52
Current Price
$45.37
Current
$45.37
$45.37
Target
$12.80
$12.80
$8.80
$12.80 avg
$18.52
Scenario Analysis
Bear Case
$8.80
-80.6%
Low target
Base Case
$12.80
-71.8%
Avg target
Bull Case
$18.52
+-59.2%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$47.84
-5.2% from high
52-Week Low
$7.40
+513.1% from low
Target vs 52W High
$12.80
-73.2% vs high
Next Earnings Report
Aug 19, 2026
9d
until earnings
EPS Est: $-0.97
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |